Charles Rivera: Unscripted

CRB appoints veteran John R. Lupa, Jr. to spearhead national construction, a strategic move to dominate the booming life sciences and food facility market.

With new deals and veteran leadership, Kane Biotech is relaunching its revyve® wound gel to combat chronic wound biofilms in the US and Canada.

A mechanics union has secured a new contract but now faces a new battle, vowing to protect jobs and safety standards as two major airlines plan to merge.

New partnerships expand Cadence's remote patient care, using data to slash hospital visits, cut costs, and empower seniors to live healthier at home.

Social Commerce Partners Corp. begins separate trading for its shares and warrants, a key step as it navigates a tough market to find a target in direct selling.

AWOL Vision's new 4K projector raised a record $10M in 12 hours, signaling a massive consumer shift from premium TVs to immersive home cinema.

A new partnership with Uniphar will use managed access programs to provide the lymphoma therapy LYMPHIR to European patients with limited treatment options.

After a challenging 2025, Lennox sets the stage for its March 4 Investor Day, where it will reveal new long-term growth targets to a watchful market.

The Oscar-nominated actress will be honored for her collaborative spirit, especially for her iconic transformation in the hit film 'Weapons'.

A new survey shows most family firms expect a leadership change soon, but few are prepared, creating a high-stakes gap between intent and action.

Vention's new AI lets robots work without training, promising to slash deployment times, redefine manufacturing ROI, and usher in a new era of automation.

A new national study finds teens are overwhelmed by online extremism and want classrooms to become safe havens for learning how to talk, not just what to think.

Global giant CSL taps Swiss biotech Memo Therapeutics in a landmark deal, signaling a major shift from plasma to lab-grown immunotherapies.

The 2026 Iron Workers/IMPACT conference will address labor shortages, new tech like mass timber, and a growing mental health crisis in construction.

AtlasFX's award-winning BankMinder brings data-driven transparency to FX risk, promising to slash hidden costs and empower corporate treasurers.

Denver-based AAI secures major private equity backing to scale its tech-driven platform, promising rapid expansion and enhanced support for independent agents.

As Amwell prepares its 2025 results, investors watch to see if its strategic pivot to profitability can redefine the future of digital healthcare.

A new drug from Bayer dramatically cuts recurrent stroke risk by 26% without the dangerous bleeding side effects of current therapies, offering hope to millions.

Over 80 institutions adopt Wellspring's Evolve, signaling a major shift in IP management as the industry races to modernize ahead of AUTM 2026.

Veteran storytellers Ann and John Cinnamon release a memoir that shuns curated posts for the real story of travel, partnership, and shared humanity.